POMDOCTOR Ltd (POM) income statement
POMNasdaqRetail-Miscellaneous RetailFiscal year ends December 31
$1.70+0.08 (+5.28%)
Close on Nov 20, 2026Market cap $235.77MP/E –Yield –
POMDOCTOR Ltd financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $235.77MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin | 13.1% | 13.9% | 12.7% | – |
| Operating margin | -29.7% | -7.5% | -7.3% | – |
| Pre-tax margin | -32.7% | -10.9% | -12.1% | – |
| Free cash flow margin | -37.4% | -4.7% | -15.1% | – |
| Returns on capital | ||||
| Return on equity | 15.6% | 6.5% | 7.1% | – |
| Return on invested capital | 7.0% | 0.91% | – | – |
| Return on capital employed | 97.4% | 19.4% | – | – |
| Return on total capital | 9.0% | 1.2% | – | – |
| NOPAT | -93.72M | -20.38M | -17.58M | – |
| Cash flow quality | ||||
| OCF / Sales | -37.1% | -4.7% | -15.0% | – |
| FCF / OCF | 100.7% | 100.2% | 100.2% | – |
| Unlevered free cash flow | -146.37M | -13.30M | -44.39M | – |
| Levered free cash flow | -149.49M | -16.17M | -45.91M | – |
| Efficiency | ||||
| Asset turnover | 5.20 | 7.41 | – | – |
| Fixed asset turnover | 468.30 | 742.49 | – | – |
| Receivables turnover | 29.83 | 40.90 | – | – |
| Days sales outstanding | 12.2 | 8.9 | – | – |
| Payables turnover | 9.91 | 11.65 | – | – |
| Days payables outstanding | 36.8 | 31.3 | – | – |
| Inventory turnover | 39.85 | 32.17 | – | – |
| Days inventory outstanding | 9.2 | 11.3 | – | – |
| Operating cycle | 21.4 | 20.3 | – | – |
| Cash conversion cycle | -15.4 | -11.1 | – | – |
| CapEx to revenue | 0.25% | 0.01% | 0.04% | – |
| CapEx to OCF | -0.68% | -0.23% | -0.24% | – |
| Liquidity | ||||
| Current ratio | 0.48 | 0.21 | – | – |
| Quick ratio | 0.44 | 0.16 | – | – |
| Cash ratio | 0.04 | 0.04 | – | – |
| Working capital | -113.20M | -141.65M | – | – |
| Net current asset value | -483.89M | -508.41M | – | – |
| Leverage | ||||
| Total debt | 63.00M | 34.96M | – | – |
| Net debt | 53.42M | 27.31M | – | – |
| Debt / Equity | -0.14 | -0.02 | – | – |
| Debt ratio | 58.6% | 75.6% | – | – |
| Assets to equity | -0.24 | -0.02 | – | – |
| Total debt / Capitalization | -16.1% | -1.6% | – | – |
| Cash flow to debt | -235.7% | -46.1% | – | – |
| Interest coverage | ||||
| EBIT / Interest expense | -30.11 | -7.10 | -11.61 | – |
| Per share | ||||
| Revenue per share | 41.31 | 54.29 | 48.31 | – |
| EPS (basic) | -21.96 | -22.72 | -23.04 | – |
| EPS (diluted) | -21.96 | -22.72 | -23.04 | – |
| Book value per share | -46.89 | -358.69 | -335.97 | – |
| Tangible book value per share | -46.89 | -358.69 | -335.97 | – |
| Cash per share | 0.99 | 1.21 | 1.06 | – |
| Operating cash flow per share | -15.34 | -2.56 | -7.26 | – |
| Free cash flow per share | -15.44 | -2.56 | -7.28 | – |
| CapEx per share | 0.10 | 0.0060 | 0.02 | – |
| Valuation at period end | ||||
| Market cap | 200.97M | – | – | – |
| Enterprise value | 204.88M | – | – | – |
| P/S | 0.5x | – | – | – |
| P/B | -0.4x | – | – | – |
| P/TBV | -0.4x | – | – | – |
| P/Gross profit | 3.8x | – | – | – |
| P/OCF | -1.4x | – | – | – |
| EV/Sales | 0.5x | – | – | – |
| EV/Gross profit | 3.9x | – | – | – |
| EV/OCF | -1.4x | – | – | – |
| FCF yield | -74.4% | – | – | – |
| Shareholder yield | ||||
| Debt paydown yield | 0.06% | – | – | – |
| Cost structure | ||||
| R&D to revenue | 3.2% | 0.88% | 1.1% | – |
| SG&A to revenue | 39.0% | 19.9% | 18.4% | – |
| Stock-based comp to revenue | 4.1% | – | – | – |
| Per employee | ||||
| Total employees | 10,000 | 10,000 | 10,000 | 10,000 |
| Revenue per employee | 39.99K | 34.26K | 30.49K | – |
| Gross profit per employee | 5.23K | 4.77K | 3.87K | – |
| Operating profit per employee | -11.86K | -2.58K | -2.22K | – |
| Free cash flow per employee | -14.95K | -1.62K | -4.59K | – |
| Growth | ||||
| Revenue 1Y growth | 16.7% | 12.4% | – | – |
| Gross profit 1Y growth | 9.6% | 23.2% | – | – |
| EBIT 1Y growth | -360.0% | -15.9% | – | – |
| Diluted EPS 1Y growth | 3.3% | 1.4% | – | – |
| Operating cash flow 1Y growth | -820.5% | 64.8% | – | – |
| Free cash flow 1Y growth | -824.6% | 64.8% | – | – |
| CapEx 1Y growth | 2,567.9% | -66.2% | – | – |
| Total assets 1Y growth | 132.7% | – | – | – |
| Total equity 1Y growth | 79.9% | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.